DR. REDDY’S LABORATORIES LIMITED Cash And Cash Equivalents
DR. REDDY’S LABORATORIES LIMITED (RDY) had Cash And Cash Equivalents of INR 14.65 billion as of 2025-03-31, per its 20-F filed 2025-06-06.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalents · last filed 2025-06-06
- 2025-03-31: Cash And Cash Equivalents 14.65B INR.
- 2024-03-31: Cash And Cash Equivalents 7.11B INR.
- 2023-03-31: Cash And Cash Equivalents 5.78B INR.
- 2022-03-31: Cash And Cash Equivalents 14.85B INR.
INR
| Period end | Cash And Cash Equivalents |
|---|---|
| 2025-03-31 | 14.65B INR 20-F · filed 2025-06-06 |
| 2024-03-31 | 7.11B INR 20-F · filed 2025-06-06 |
| 2023-03-31 | 5.78B INR 20-F · filed 2024-06-12 |
| 2022-03-31 | 14.85B INR 20-F · filed 2023-06-13 |
| 2021-03-31 | 14.83B INR 20-F · filed 2022-06-27 |
| 2020-03-31 | 2.05B INR 20-F · filed 2021-06-30 |
| 2019-03-31 | 2.23B INR 20-F · filed 2020-06-15 |
| 2018-03-31 | 2.64B INR 20-F · filed 2019-06-03 |
| 2017-03-31 | 3.87B INR 20-F · filed 2018-07-12 |
USD
| Period end | Cash And Cash Equivalents |
|---|---|
| 2025-03-31 | $172.00M 20-F · filed 2025-06-06 |
| 2024-03-31 | $85.00M 20-F · filed 2024-06-12 |
| 2023-03-31 | $70.00M 20-F · filed 2023-06-13 |
| 2022-03-31 | $196.00M 20-F · filed 2022-06-27 |
| 2021-03-31 | $203.00M 20-F · filed 2021-06-30 |
| 2020-03-31 | $27.00M 20-F · filed 2020-06-15 |
| 2019-03-31 | $32.00M 20-F · filed 2019-06-03 |
| 2018-03-31 | $41.00M 20-F · filed 2018-07-12 |